Literature DB >> 21917736

MicroRNA regulation of cancer stem cells.

Can Liu1, Dean G Tang.   

Abstract

Cancer stem cells (CSC), or cancer cells with stem cell properties, have been reported in many human tumors and are thought to be responsible for tumor initiation, therapy resistance, progression, relapse, and metastasis. Despite their potential clinical importance, how CSCs are regulated at the molecular level is not well understood. MicroRNAs (miRNA), small noncoding RNAs that play critical roles in normal stem cell functions during development, have emerged as important regulators of CSCs as well. In this review, we summarize the current major findings of miRNA regulation of various CSCs and discuss our recent findings that miR-34a suppresses prostate CSCs and metastasis by directly repressing CD44. This recent progress has important implications for understanding how CSCs are intricately regulated by networks of miRNAs and for developing novel mechanism-based miRNA therapeutics that specifically target CSCs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21917736      PMCID: PMC3177108          DOI: 10.1158/0008-5472.CAN-11-1035

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

1.  Prospective identification of tumorigenic prostate cancer stem cells.

Authors:  Anne T Collins; Paul A Berry; Catherine Hyde; Michael J Stower; Norman J Maitland
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

2.  DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal.

Authors:  Yangming Wang; Rostislav Medvid; Collin Melton; Rudolf Jaenisch; Robert Blelloch
Journal:  Nat Genet       Date:  2007-01-28       Impact factor: 38.330

3.  RNA sequence analysis defines Dicer's role in mouse embryonic stem cells.

Authors:  J Mauro Calabrese; Amy C Seila; Gene W Yeo; Phillip A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-07       Impact factor: 11.205

4.  Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing.

Authors:  Chryssa Kanellopoulou; Stefan A Muljo; Andrew L Kung; Shridar Ganesan; Ronny Drapkin; Thomas Jenuwein; David M Livingston; Klaus Rajewsky
Journal:  Genes Dev       Date:  2005-02-15       Impact factor: 11.361

Review 5.  MicroRNA signatures in human cancers.

Authors:  George A Calin; Carlo M Croce
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

6.  Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells.

Authors:  L Patrawala; T Calhoun; R Schneider-Broussard; H Li; B Bhatia; S Tang; J G Reilly; D Chandra; J Zhou; K Claypool; L Coghlan; D G Tang
Journal:  Oncogene       Date:  2006-03-16       Impact factor: 9.867

7.  Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.

Authors:  Lubna Patrawala; Tammy Calhoun; Robin Schneider-Broussard; Jianjun Zhou; Kent Claypool; Dean G Tang
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

8.  Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells.

Authors:  Lubna Patrawala; Tammy Calhoun-Davis; Robin Schneider-Broussard; Dean G Tang
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

9.  Dicer is essential for mouse development.

Authors:  Emily Bernstein; Sang Yong Kim; Michelle A Carmell; Elizabeth P Murchison; Heather Alcorn; Mamie Z Li; Alea A Mills; Stephen J Elledge; Kathryn V Anderson; Gregory J Hannon
Journal:  Nat Genet       Date:  2003-10-05       Impact factor: 38.330

10.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors:  Can Liu; Kevin Kelnar; Bigang Liu; Xin Chen; Tammy Calhoun-Davis; Hangwen Li; Lubna Patrawala; Hong Yan; Collene Jeter; Sofia Honorio; Jason F Wiggins; Andreas G Bader; Randy Fagin; David Brown; Dean G Tang
Journal:  Nat Med       Date:  2011-01-16       Impact factor: 53.440

View more
  115 in total

1.  Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer.

Authors:  C Coarfa; W Fiskus; V K Eedunuri; K Rajapakshe; C Foley; S A Chew; S S Shah; C Geng; J Shou; J S Mohamed; B W O'Malley; N Mitsiades
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

2.  Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells.

Authors:  Amit Kumar Srivastava; Chunhua Han; Ran Zhao; Tiantian Cui; Yuntao Dai; Charlene Mao; Weiqiang Zhao; Xiaoli Zhang; Jianhua Yu; Qi-En Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

Review 3.  Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness.

Authors:  Bin Bao; Asfar S Azmi; Yiwei Li; Aamir Ahmad; Shadan Ali; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Curr Stem Cell Res Ther       Date:  2014-01       Impact factor: 3.828

Review 4.  Can nanomedicines kill cancer stem cells?

Authors:  Yi Zhao; Daria Y Alakhova; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

Review 5.  MicroRNAs are involved in the self-renewal and differentiation of cancer stem cells.

Authors:  Zheng-ming Wang; Wen-jun Du; Gary A Piazza; Yaguang Xi
Journal:  Acta Pharmacol Sin       Date:  2013-10-14       Impact factor: 6.150

6.  Pigmy MicroRNA: surveillance cops in Therapies kingdom.

Authors:  Utpal Bhadra; Pradipta Patra; Jagamohan Chhatai; Manika Pal-Bhadra
Journal:  Mol Med       Date:  2016-09-28       Impact factor: 6.354

7.  Aberrant microRNA expression likely controls RAS oncogene activation during malignant transformation of human prostate epithelial and stem cells by arsenic.

Authors:  Ntube N O Ngalame; Erik J Tokar; Rachel J Person; Yuanyuan Xu; Michael P Waalkes
Journal:  Toxicol Sci       Date:  2014-01-15       Impact factor: 4.849

Review 8.  Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications.

Authors:  Qu Deng; Dean G Tang
Journal:  Endocr Relat Cancer       Date:  2015-08-18       Impact factor: 5.678

9.  MicroRNAs: New players in cancer prevention targeting Nrf2, oxidative stress and inflammatory pathways.

Authors:  Chengyue Zhang; Limin Shu; Ah-Ng Tony Kong
Journal:  Curr Pharmacol Rep       Date:  2015-01-11

10.  Regulation of lung cancer metastasis by Klf4-Numb-like signaling.

Authors:  Valentina Vaira; Alice Faversani; Nina M Martin; David S Garlick; Stefano Ferrero; Mario Nosotti; Joseph L Kissil; Silvano Bosari; Dario C Altieri
Journal:  Cancer Res       Date:  2013-02-25       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.